Rockefeller Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,700
| Closed | -$25K | – | 2120 |
|
|
2022
Q4 | $25K | Hold |
2,700
| – | – | ﹤0.01% | 2708 |
|
|
2022
Q3 | $27K | Hold |
2,700
| – | – | ﹤0.01% | 2636 |
|
|
2022
Q2 | $27K | Hold |
2,700
| – | – | ﹤0.01% | 2566 |
|
|
2022
Q1 | $33K | Buy |
2,700
+1,500
| +125% | +$18.3K | ﹤0.01% | 2494 |
|
|
2021
Q4 | $20K | Hold |
1,200
| – | – | ﹤0.01% | 2638 |
|
|
2021
Q3 | $21K | Buy |
1,200
+400
| +50% | +$7K | ﹤0.01% | 2555 |
|
|
2021
Q2 | $18K | Buy |
800
+300
| +60% | +$6.75K | ﹤0.01% | 2518 |
|
|
2021
Q1 | $7K | Buy |
+500
| New | +$7K | ﹤0.01% | 2729 |
|